Who is sponsoring NCT04434313?

NCT04434313 is sponsored by Moterum Technologies, Inc..

What drugs are being tested in NCT04434313?

Interventions in NCT04434313: Delivery of iStride™ device gait treatment using telemedicine.

What condition does NCT04434313 study?

NCT04434313 studies Telemedicine, Gait, Hemiplegic, Gait Disorders, Neurologic, Stroke, Orthotic Devices, Gait Analysis.

Is NCT04434313 still recruiting?

NCT04434313 is currently completed. Last updated 7 September 2022.

Last reviewed 2022-09-07 · How we verify

NCT04434313

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Treatment of Hemiparetic Gait Impairments Using Telehealth With the Moterum iStride Solution™

Completed NA Last updated 7 September 2022

What this trial tests

NA trial testing Delivery of iStride™ device gait treatment using telemedicine in Telemedicine in 6 participants. Completed in 21 December 2020.

Timeline

20 April 2020

Primary endpoint
19 December 2020

21 December 2020

Quick facts

Lead sponsor	Moterum Technologies, Inc.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	6
Start date	20 April 2020
Primary completion	19 December 2020
Estimated completion	21 December 2020
Sites	1 location across United States

Drugs / interventions tested

Delivery of iStride™ device gait treatment using telemedicine

Conditions studied

Telemedicine — all drugs for Telemedicine →
Gait, Hemiplegic — all drugs for Gait, Hemiplegic →
Gait Disorders, Neurologic — all drugs for Gait Disorders, Neurologic →
Stroke — all drugs for Stroke →

Sponsor

Moterum Technologies, Inc.

Who can join

Adults 21 to 80, any sex, with Telemedicine or Gait, Hemiplegic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this research is to investigate the feasibility of delivering gait treatment using the Moterum iStride Solution™ to individuals with hemiparetic gait impairments using a telemedicine modality, the Moterum Digital Platform.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Gait Device Treatment Using Telehealth for Individuals With Stroke During the COVID-19 Pandemic: Nonrandomized Pilot Feasibility Study.
Darcy B, Rashford L, Shultz ST, Tsai NT, et al · · 2023 · cited 5× · PMID 37204830 · DOI 10.2196/43008

Verify or expand the search:

Other recruiting trials for Telemedicine

Currently open trials in the same condition.

NCT07265037 — Integrated TCM - Western Medicine Strategy for Long - Distance Diabetes Management · NA · recruiting
NCT07042477 — Integrated Telemedicine Program Evaluation · NA · recruiting
NCT07124325 — Remote Cardiotocography Telemonitoring Within High-risk Pregnancy Care · NA · recruiting
NCT06942533 — Effect of Visual Feedback From the SpiroGym Mobile Application · NA · recruiting
NCT06980740 — Video-Tumorboard PLUS · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04434313 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Moterum Technologies, Inc.
Last refreshed: 7 September 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04434313.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing